Opill February 1, 2024 On July 13, 2023, the FDA approved the first over-the-counter birth control called ‘Opill’. An increased availability of hormonal birth control without a prescription may increase access and remove the barriers that individuals Read More
Compounding Pharmacies vs. Big Pharma: The Battle for Dominance in the Growing GLP-1 Market October 22, 2024